Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: A practical approach to clinical decision making-Reference-Cited by-同舟云学术

Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: A practical approach to clinical decision making

Published:2013-07 Issue:7 Volume:49 Page:676-683
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Tuttle R. Michael,Sabra Mona M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference36 articles.

1. Management of low-risk differentiated thyroid cancer;Mazzaferri;Endocr Pract,2007

2. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer;Mazzaferri;J Clin Endocrinol Metab,2001

3. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma;Hay;J Surg Oncol,2006

4. Management of patients with low-risk papillary thyroid carcinoma;Hay;Endocr Pract,2007

5. Contemporary post surgical management of differentiated thyroid carcinoma;Tala;Clin Oncol (R Coll Radiol),2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma;The Journal of Clinical Endocrinology & Metabolism;2024-08-01

2. Advances in the selection and timing of postoperative radioiodine treatment in patients with differentiated thyroid carcinoma;Annals of Nuclear Medicine;2024-07-24

3. Comparison of Models Predicting Efficacy of Radioiodine Therapy in Patients with Differentiated Thyroid Cancer;2024-07-23

4. Current practice in intermediate risk differentiated thyroid cancer – a review;Reviews in Endocrine and Metabolic Disorders;2023-11-23

5. Effect of recombinant human thyroid stimulating hormone on long-term salivary gland dysfunction in thyroid cancer patients treated with radioactive iodine. A systematic review;Oral Oncology;2023-01